Molecular Partners AG (MOLN)
NASDAQ: MOLN · Real-Time Price · USD
6.57
-0.21 (-3.10%)
At close: Oct 22, 2024, 4:00 PM
6.28
-0.29 (-4.41%)
Pre-market: Oct 23, 2024, 6:49 AM EDT
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of $222.58 million as of October 23, 2024. Its market cap has increased by 65.36% in one year.
Market Cap
222.58M
Enterprise Value
42.14M
1-Year Change
65.36%
Ranking
Category
Stock Price
$6.57
Market Cap Chart
Since the IPO on June 16, 2021, Molecular Partners AG's market cap has decreased from $683.35M to $222.58M, a decrease of -67.43%. That is a compound annual growth rate of -28.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2024 | 225.00M | 63.87% |
| Dec 29, 2023 | 137.30M | -35.54% |
| Dec 30, 2022 | 213.00M | -65.47% |
| Dec 31, 2021 | 616.80M | -9.74% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| The Joint | 175.46M |
| Achieve Life Sciences | 174.45M |
| Sagimet Biosciences | 172.65M |
| Lineage Cell Therapeutics | 171.84M |
| Acumen Pharmaceuticals | 171.83M |
| Stereotaxis | 167.11M |
| Galectin Therapeutics | 166.28M |
| BrainsWay | 165.46M |